Has anyone heard news of Dr Skinner IOP. It seems very quiet on this forum, normally someone has posted or have I missed it?
Thanks
Has anyone heard news of Dr Skinner IOP. It seems very quiet on this forum, normally someone has posted or have I missed it?
Thanks
If you're a member of TPA UK there's a post on there with an update on how things went (which weren't well).
Saw him yesterday. Said it didn't go well but as usual he was positive . Didn't say much about what happened . I have an appointment in 6 months so I'm sure if he had any concerns he would have said something
I am a patient of dr skinner too, so looked at the TPA website; copied this.
Monday 7 October 1013 - 9.30am: Dr Skinner has received notification that an Interim Orders Panel (IOP) will take place at the MPTS, St James's Buildings, 79, Oxford Street, Manchester, M1 6FQ.
Dr Skinner has asked this to be a public IOP so patients will be allowed in as always.
It is VERY important that as many people as possible should try to attend as this makes such a difference, and it is also very important that if you wish to write a letter of support for Dr Skinner, you do this as quickly as possible.
Even if you have written letters of support for him before, such letters are NOT automatically passed to the GMC Panel, as each IOP is considered a new case. Please send a copy to Afshan, and if you have any questions, write to her on afshan@vri.org.uk.
Dr Skinner's case number is: LG/C1-462487326.
Please send your letter of Support to:
Ms Lucy Galbraith,
Investigation Officer,
Fitness to Practice Directorate,
3 Hardman Street,
Manchester,
M3 3AW
Email: lgalbraith@gmc-uk.org
Friday, 25 October 2013 - 11.30a.m: TPA Annual Conference: The Novotel, 70 Broad Street, Birmingham B1 2HT - Tickets £15 to include Hot and Cold Buffet
I am a patient of Dr Skinner and also concerned. Does anyone know what happened on the 7th?
From GMC website, no idea if these differ from previous conditions, as he's not my doctor so while take an interest I have no reason to remember the facts
07 Oct 2013 -23 Nov 2013
1. He must notify the GMC promptly of any professional appointment he accepts for which registration with the GMC is required and provide the contact details of his employer.
Details
2. He must allow the GMC to exchange information with any employer he may have or any contracting body for which he provides medical services.
3. He must inform the GMC of any formal disciplinary proceedings taken against him, from the date of this determination.
4. He must inform the GMC if he applies for medical employment outside the UK.
5. a. His clinical work in relation to prescribing of thyroid replacement therapy must be supervised by a named Consultant Endocrinologist. This means that his day to day work must be supervised by this consultant who may be off site but must be available to be called if necessary. However, as a minimum, his work must be reviewed at least once a fortnight by the supervising consultant. This review should include regular case based discussions, with reference to his logbook. This logbook may additionally be provided in an electronic format agreed with his supervisor. b. He must seek a report from his supervisor for consideration by this Panel, prior to any review hearing of this Panel.
6. In any patient with normal thyroid function test results and with a history of cardiac disease, he should not initiate treatment with Thyroxine without first having an opinion from the patient’s cardiologist or GP, which should be recorded in his logbook.
7. He must keep a contemporaneous logbook of all patients for whom he prescribes or recommends thyroid replacement therapy. This book must identify the patient only by their initials and NHS number together with the name and contact number of the referring practitioner, and should be initialled and dated by the patient. a. The logbook he keeps must indicate: i. The reason for the prescription of thyroid replacement treatment; ii. The most recent thyroid blood test results, dated, regardless of whether or not the blood test was carried out by a general practitioner or himself; and iii. The dose he has prescribed or recommended of thyroid replacement treatment. b. This logbook must be available for consideration by this Panel, prior to any review hearing of this Panel. In addition, any electronic version of the logbook should be available to the Panel.
8. He must inform the following parties that his registration is subject to the conditions, listed at (1) to (7), above: a. Any organisation or person employing or contracting with him to undertake medical work b. Any locum agency he is registered with or applies to be registered with (at the time of application) c. Any prospective employer or contracting body (at the time of application).
Thanks for all your replies.
They allow a doctor who has killed patients with overdoses higher than Dr Shipman used, to continue practicing! but they continue to hound Dr S. He is past retirement age and could have packed up and be stress free. You wonder why he keeps being pestered by the GMC. Obviously the 'powers that be' don't like the fact that he does what he was taught as a medical student and is able to judge who is hypo by clinical symptoms too and he isn't an Endocrinologist, so that aggravates them.
Yes - why is it that in this country doctors who prescribe T3 and NDT, taking symptoms into account, are hounded and vilified, whereas T3 is freely available over the counter in countries like Crete at a cost of 3 euros something for 3 boxes of 25 mcg? If it were really dangerous it should not and hopefully would not be available anywhere without prescription in 'unified' Europe. There is no rhyme or reason to it.